Shared Care Guidelines inc. Out of Area Shared Care Guidelines

ADHD In Children

Indications

ADHD in children

Last updated date

Oct 2023

Review date

Sept 2026

Acamprosate (For patients seen by/referred to the Derbyshire Recovery partnership)

Indications

Alcohol abstinence

Last updated date

Dec 2022

Review date

Nov 2025

Amiodarone

Indications

Treatment of severe heart rhythm disorder when other treatments cannot be used

Last updated date

Aug 2023

Review date

July 2026

Apomorphine

Indications

Parkinson's Disease

Last updated date

Aug 2021

Review date

July 2025

Azathioprine and 6-mercaptopurine

Indications

Immunomodulating drugs

Last updated date

Sept 2023

Review date

Aug 2026

Azithromycin

Indications

For use in adult respiratory infections

Last updated date

Aug 2022

Review date

July 2025

Buprenorphine

Indications

Substance Misuse

Last updated date

Dec 2021

Review date

Nov 2024

Ciclosporin

Indications

Immunomodulating drugs

Last updated date

Aug 2023

Review date

July 2026

Degarelix

Indications

Advanced hormone-dependant prostate cancer

Last updated date

May 2022

Review date

Apr 2025

Denosumab

Indications

Osteoporotic fractures in men and post-menopausal women

Last updated date

June 2022

Review date

May 2025

Disulfiram (For patients seen by/referred to the Derbyshire Recovery partnership)

Indications

Maintenance of alcohol abstinence

Last updated date

Dec 2022

Review date

Nov 2025

Dronedarone

Indications

For the maintenance of sinus rhythm after successful cardioversion

Last updated date

Aug 2023

Review date

July 2026

Lanreotide and Octreotide

Indications

Somatostatin analogues

Last updated date

Jan 2021

Review date

Dec 2024

Leflunomide

Indications

Immunomodulating drugs

Last updated date

Sept 2023

Review date

Aug 2026

Liothyronine in combination with levothyroxine

Indications

Hypothyroidism

Last updated date

Nov 2022

Review date

Oct 2025

Lithium

Indications

Mania, hypomania & bipolar disorder

Last updated date

June 2023

Review date

May 2026

Mercaptopurine/Azathioprine

Indications

Immunomodulating drugs

Last updated date

Sept 2023

Review date

Aug 2026

Methadone

Indications

Substance Misuse

Last updated date

Dec 2021

Review date

Nov 2024

Methotrexate

Indications

Immunomodulating drugs

Last updated date

June 2023

Review date

May 2026

Mycophenolate mofetil

Indications

Immunomodulating drugs (Non transplant indications)

Last updated date

Apr 2023

Review date

Mar 2026

Naltrexone

Indications

Substance opioid misuse

Last updated date

Dec 2021

Review date

Nov 2024

Naltrexone (for alcohol misuse)

Indications

Substance alcohol misuse

Last updated date

Dec 2022

Review date

Nov 2025

Penicillamine

Indications

Immunomodulating drugs

Last updated date

June 2023

Review date

May 2026

Riluzole

Indications

Motor Neurone Disease

Last updated date

June 2023

Review date

May 2026

Somatropin

Indications

Synthetic Human Growth Hormone

Last updated date

Aug 2021

Review date

July 2024

Sulfasalazine

Indications

Immunomodulating drugs

Last updated date

Oct 2023

Review date

Sept 2026

Vigabatrin (for UHDB only)

Indications

Children with epilepsy

Last updated date

Jan 2021

Review date

Dec 2024